IL1B and colitis: In this regard, the suitability of this model was corroborated by the efficacy of DEX to ameliorate the macroscopic and histological features of colitis as well as to reduce tissue TNF and IL-1β levels, in line with previous reports showing similar beneficial effects of this glucocorticoid drugs [18, 28].